These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7214856)

  • 21. [Silymarin in chronic liver diseases].
    Müscher CH
    Ther Ggw; 1972 Dec; 111(12):1768-70 passim. PubMed ID: 4569030
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapeutic effect of silymarin in patients with liver cirrhosis].
    Kupcová V; Turecký L; Holomán J; Ulicná O; Brixová E; Volmut J
    Cas Lek Cesk; 1987 Nov; 126(45):1406-9. PubMed ID: 3427593
    [No Abstract]   [Full Text] [Related]  

  • 23. [The liver--a therapeutic target in dermatoses].
    Weber G; Galle K
    Med Welt; 1983 Jan; 34(4):108-11. PubMed ID: 6827974
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapy of liver diseases using Silymarin (Legalon)].
    Milosavljevic Z
    Ther Ggw; 1973 Jun; 112(6):968 passim. PubMed ID: 4200154
    [No Abstract]   [Full Text] [Related]  

  • 25. [Metabolic impairment of the hepatocyte in pregnancy: prevention and therapy with a membrane-stabilizing drug].
    Maneschi M; Tiberio C; Cittadini E
    Clin Ter; 1981 Jun; 97(6):625-30. PubMed ID: 6268349
    [No Abstract]   [Full Text] [Related]  

  • 26. [Silymarin in pregnancy and during hormonal contraceptive treatment. Blood chemistry and ultrastructural findings in the experimental model].
    Martines G; Piva M; Copponi V; Cagnetta G
    Arch Sci Med (Torino); 1979; 136(3):443-54. PubMed ID: 549550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sylimarine in the treatment of chronic hepatitis].
    Sawaryn T; Szymoński K; Machalska M
    Przegl Epidemiol; 1977; 31(4):445-50. PubMed ID: 607279
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapy of hepatoses. Therapeutic use of Silymarin].
    Schopen RD; Lange OK
    Med Welt; 1970 Apr; 15():691-8. PubMed ID: 5523243
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical study of the therapeutic action of silymarin in acute infectious hepatitis in childhood].
    Mingrino F; Tosti U; Anania S; Buglioni MC; Viola F
    Minerva Pediatr; 1979 Mar; 31(6):451-6. PubMed ID: 470888
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapy of hepatic diseases in ambulatory medicine. Multicenter studies].
    Martines G; Mingrino GC; Cagnetta G; Copponi V
    Clin Ter; 1980 Jan; 92(1):33-58. PubMed ID: 7449307
    [No Abstract]   [Full Text] [Related]  

  • 31. [Legalon in the complex treatment of patients with hepatic stasis in chronic circulatory insufficiency].
    Krylov AA
    Vrach Delo; 1984 Mar; (3):22-3. PubMed ID: 6719894
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of silymarin and (+)-cyanidanol-3 on hexachlorobenzene(HCB)-induced porphyria in rats].
    Siegers CP
    Z Gastroenterol; 1982 Dec; 20(12):757-8. PubMed ID: 7164529
    [No Abstract]   [Full Text] [Related]  

  • 33. [Sylimarol in the treatment of acute viral hepatitis].
    Tkacz B; Dworniak D
    Wiad Lek; 1983 Apr; 36(8):613-6. PubMed ID: 6353775
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapeutic effect of silymarin on x-irradiated mice].
    Flemming K
    Arzneimittelforschung; 1971 Sep; 21(9):1373-5. PubMed ID: 5171794
    [No Abstract]   [Full Text] [Related]  

  • 35. [Silymarin in the prevention of hepatic damage by psychopharmacologic drugs. Experimental premises and clinical evaluations].
    Carrescia O; Benelli L; Saraceni F; Braga PC; Cagnetta G; Copponi V
    Clin Ter; 1980 Oct; 95(2):157-64. PubMed ID: 7471652
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effectiveness of legalon and essentiale in a tetracycline-induced liver lesion].
    Skakun NP; Stepanova NIu
    Antibiot Med Biotekhnol; 1986 Oct; 31(10):781-4. PubMed ID: 3789688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of silymarin in intrahepatic cholestasis of pregnancy (preliminary communication)].
    Hernández R; Nazar E
    Rev Chil Obstet Ginecol; 1982; 47(1):22-9. PubMed ID: 6927150
    [No Abstract]   [Full Text] [Related]  

  • 38. Re: Flora et al. Silymarin for the therapy of liver disease.
    Bode JC
    Am J Gastroenterol; 1999 Feb; 94(2):545-6. PubMed ID: 10022676
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experimental clinical study with Silimarin in the treatment of diffuse liver diseases of potentially reversible nature].
    Güemes Díaz F; Pérez Muñóz C; Sallent Herránz J; Arias Vallejo E
    Rev Clin Esp; 1974 Feb; 132(3):263-8. PubMed ID: 4841954
    [No Abstract]   [Full Text] [Related]  

  • 40. [The use of silymarin and SAMe in the treatment of acute infective hepatitis in childhood].
    Musso A; Giacchino M; Vietti M; Vaccino P; Cerutti A
    Minerva Pediatr; 1980 Sep; 32(17):1057-67. PubMed ID: 7453688
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.